期刊文献+

非对称性二甲基精氨酸与血管内皮功能 被引量:4

Asymmetric Dimethylarginine and Function of Vascular Endothelium
下载PDF
导出
摘要 非对称性二甲基精氨酸是内源性一氧化氮合酶抑制剂,研究表明,非对称性二甲基精氨酸与血管内皮功能失调密切相关,血浆中非对称性二甲基精氨酸水平的升高是内皮功能失调的新的危险因子。 Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase.Studies have indicated that asymmetric dimethylarginine is closely correlated with endothelial dysfunction and increased plasma levels of this inhibitor may be a novel risk factor of endothelial dysfunction.
出处 《心血管病学进展》 CAS 2005年第2期175-177,共3页 Advances in Cardiovascular Diseases
关键词 非对称性二甲基精氨酸 血管内皮功能 内皮功能失调 危险因子 升高 血浆 酶抑制剂 合酶 中非 水平 Asymmetric dimethylarginine Nitric oxide Nitric oxide synthase Endothelial function
  • 相关文献

参考文献20

  • 1Kakimoto Y,Akazawa S.Isolation and identification of NG,NG-,and NG,N'G-dimtthyl-arginine,N-mono-,di-,and trimethyllysine,and glucosylgalact- osyl-,and galactosyl-δ-hydroxylysine from human urine [J].J Biol Chem,1970,245:5751-5758.
  • 2John P.Does ADMA cause endothelial dysfunction[J]? Arterioscler Thromb Vasc Biol,2000,20(9):2032-2037.
  • 3B(o)ger RH.The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor[J].Circ Res,2003,59:824-833.
  • 4Vallance P,Leone A,Calver A,et al.Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure[J].Lancet,1992,339:572-575.
  • 5Ogawa T,Kimoto M,Sasaoka K.Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-L-arginine to L-citruline in rats[J].Biochem Biophys Res Commun,1987,148:671-677.
  • 6B(o)ger RH,Bode-B(o)ger SM,Tsao PS,et al.An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes[J].J Am Coll Cardiol,2000,36:2287-2295.
  • 7B(o)ger RH,Sydow K,Borlak J,et al.Cholesterol upregulates synthase of asymmetric dimethylarginine(ADMA)in human endothelial cells.Involvement of S-adenosylmethionine-dependent methyltransferases[J].Circ Res,2000,87:99-105.
  • 8Ito A,Tsao PS,Adimoolam S,et al.Novel mechanism for endothelial dysfunction:dysregulation of dimethylarginine dimethylamiohydrolase[J].Circulation,1999,99:3092-3095.
  • 9Tsikas D,B(o)ger RH,Sandmamm J,et al.Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox[J].FEBS Lett,2000,478:1-3.
  • 10Andrew JM.Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases[J].Nitric Oxide:Biol Chem,2002,6(2):101-124.

同被引文献50

  • 1秦薇,余艳红.妊娠期高血压疾病流行病学调查[J].实用医学杂志,2006,22(23):2697-2698. 被引量:12
  • 2Lassus P, Turanlahti M, Heikkila P, et al. Pulmonary vascular endothelial growth factor and Fit-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hyperten- sion of the newborn[J]. Am J Respir Crit Care Med, 2001, 164(10 Pt 1) :1981-1987.
  • 3Gaston B, Drazen J M, Loscalzo J, et al. The biology of nitro- gen oxides in the airways[J]. Am J Respir Crit Care Med, 1994,149(2 Pt 1):538-551.
  • 4Wells SM, Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells [J]. Am J Respir Cell Mol Biol,2007,36(5):520-528.
  • 5Wells SM, Buford MC, Migliaccio CT, et al. Elevated asym- metric dimethylarginine alters lung function and induces colla- gen deposition in mice[J]. Am J Respir Cell Mol Biol, 2009, 40(2) : 179-188.
  • 6Wojciak-Stothard B, Torondel B, Tsang LY, et al. The AD- MA/DDAH pathway is a critical regulator of endothelial cell motility[J]. J Cell Sci, 2007,120 (Pt 6) : 929-942.
  • 7Pope AJ, Karuppiah K, Cardounel AJ. Role of the PRMT- DDAH-ADMA axis in the regulation of endothelial nitric ox- ide production[J]. Pharmacol Res, 2009,60(6) : 461-465.
  • 8Tsukahara H, Ohta N, Tokuriki S, et al. Determination of asymmetric dimethylarginine, an endogenous nitric oxide syn- thase inhibitor, in umbilical blood[J]. Metabolism, 2008, 57 (2) :215-220.
  • 9Richir MC, van Leeuwen PA, van den Berg A, et al. Plasma ADMA concentrations at birth and mechanical ventilation in preterm infants: a prospective pilot study [J]. Pediatr Pul- monol,2008,43(12):1161-1166.
  • 10Bulau P,Zakrzewicz D,Kitowska K,et al. Analysis of methyl- arginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA[J]. Am J Physiol Lung Cell Mol Physiol, 2007,292 (1) : L18- L24.

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部